SCHEMBL4713233

SCHEMBL4713233

Cc1cc(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
CYP1A2 P05177 1/20 0.60
TOP2A P11388 8/20 0.58
TOP2B Q02880 8/20 0.58
KCNH2 Q12809 4/20 0.53
ALDH1A1 P00352 3/20 0.50
POLB P06746 2/20 0.50
OPRM1 P35372 2/20 0.50
CHRM2 P08172 1/20 0.50
CHRM1 P11229 1/20 0.50
OPRD1 P41143 1/20 0.50
PRKD3 O94806 1/20 0.48
HPGD P15428 1/20 0.48
ALOX15 P16050 1/20 0.48
CLK2 P49760 1/20 0.48
HSD17B10 Q99714 1/20 0.48
CLK4 Q9HAZ1 1/20 0.48
TDP1 Q9NUW8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5443905 0.87 TOP2A (0.61) KDM4ESMN1; SMN2CYP1A2TOP2ATOP2B
SCHEMBL4717920 0.85 KDM4E (0.55) KDM4ESMN1; SMN2CYP1A2TOP2ATOP2B
SCHEMBL4717918 0.85 KDM4E (0.55) KDM4ESMN1; SMN2CYP1A2TOP2ATOP2B
SCHEMBL4715010 0.85 KDM4E (0.57) KDM4ESMN1; SMN2CYP1A2TOP2ATOP2B
SCHEMBL29802253 0.84 ADRB2 (0.57) KDM4ESMN1; SMN2CYP1A2TOP2ATOP2B
SCHEMBL29433780 0.84 KDM4E (0.57) KDM4ESMN1; SMN2CYP1A2TOP2ATOP2B
SCHEMBL4717958 0.84 KDM4E (0.57) KDM4ESMN1; SMN2CYP1A2TOP2ATOP2B
SCHEMBL8365398 0.81 KDM4E (0.54) KDM4ESMN1; SMN2CYP1A2TOP2ATOP2B
SCHEMBL6171288 0.81 TOP2A (0.58) KDM4ESMN1; SMN2CYP1A2TOP2ATOP2B
SCHEMBL3136282 0.81 TOP2A (0.66) KDM4ECYP1A2TOP2ATOP2BKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1262477-B1 ANTI-ACID-FAST BACTERIAL AGENTS CONTAINING PYRIDONECARBOXYLIC ACIDS AS THE ACTIVE INGREDIENT DAIICHI SANKYO CO LTD (JP) 2008-09-03 EP claimed
US-20030119848-A1 Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-06-26 US claimed
EP-1262477-A1 ANTI-ACID-FAST BACTERIAL AGENTS CONTAINING PYRIDONECARBOXYLIC ACIDS AS THE ACTIVE INGREDIENT DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2002-12-04 EP claimed
EP-1262477-B1 ANTI-ACID-FAST BACTERIAL AGENTS CONTAINING PYRIDONECARBOXYLIC ACIDS AS THE ACTIVE INGREDIENT DAIICHI SANKYO CO LTD (JP) 2008-09-03 EP disclosed
US-7176313-B2 Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-02-13 US disclosed
US-20030119848-A1 Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-06-26 US disclosed
EP-1262477-A1 ANTI-ACID-FAST BACTERIAL AGENTS CONTAINING PYRIDONECARBOXYLIC ACIDS AS THE ACTIVE INGREDIENT DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2002-12-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030119848-A1 Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient PGD, PPA1, FASTKD1 KDM4E 3677/4885SMN1; SMN2 3603/4885CYP1A2 2156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.